サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427766

冠動脈疾患の世界市場レポート 2024

Coronary Artery Disease Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
冠動脈疾患の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

冠動脈疾患市場の成長は、冠動脈疾患（CAD）の普及の増加によって促進されると予想されます。この病状は、心筋に血液を供給する冠状動脈の狭窄または閉塞を特徴としています。 CAD症例の増加に寄与する要因には、食事の変化、ストレス、座りっぱなしのライフスタイル、肥満、加齢などが含まれます。 冠動脈疾患の治療法には、クロピドグレル、チカグレロル、ワルファリン、ヘパリンなどの薬物介入と、冠動脈バイパス移植、血管形成術、ステント留置術などの処置的アプローチが含まれます。米国疾病管理予防センターの2023年5月の報告書によると、心臓病の中で最も一般的な冠状動脈性心疾患により、2021年には37万5,476人の命が奪われ、20歳以上の成人の約5％が罹患しています。この普及は、予測期間中に冠動脈疾患市場を牽引すると予想されます。

冠動脈疾患市場の成長軌道は、高齢化人口の増加によってさらに加速されます。人口の高齢化は、社会における高齢者の割合の増加を特徴とする人口動態の変化を意味します。高齢者の方がこの症状にかかりやすいことを考えると、人口動態の傾向は冠動脈疾患市場の拡大に大きく貢献しています。世界保健機関の2022年 10月の予測によると、2030年までに世界中の6人に1人が60歳以上になるとのことです。この期間中に、60歳以上の人口は2020年の10億人から14億人に増加すると予想されています。 2050年を見据えると、60歳以上の世界人口は倍増して21億人に達すると予測されています。この人口動態の変化は、冠動脈疾患市場の推進における高齢化人口の増加の役割を強調しています。

冠動脈疾患市場内の著名な企業は、AIベースの血液検査などの最先端技術の開発に注力しています。これらの検査では、血液関連データの分析と解釈に人工知能（AI）アルゴリズムを活用しています。たとえば、2023年 2月、AIベースの統合遺伝子エピジェネティックエンジンを専門とする米国に本拠を置く企業Cardio Diagnostics Holdingsは、PrecisionCHDを導入しました。この革新的な血液検査は、遺伝的分析とエピジェネティックな分析を組み合わせて、冠状動脈性心疾患の早期特定を可能にします。男性と女性の両方で75%以上の感度を備えたPrecisionCHDは、エピジェネティック（DNAメチル化）および遺伝的（一塩基多型）バイオマーカーを組み込んだ、数十億のゲノムおよびエピゲノムデータポイントの分析から得られた機械学習モデルを採用しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の冠動脈疾患市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 薬剤
  • 手術
  • 追加の治療
  • その他
  • 世界の冠動脈疾患市場、診断別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 心電図
  • 心エコー図
  • ストレステスト
  • 心臓カテーテル
  • 心臓CTスキャン
  • その他
  • 世界の冠動脈疾患市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他
  • 世界の冠動脈疾患市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 専門クリニック
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の冠動脈疾患市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の冠動脈疾患市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 冠動脈疾患市場の競合情勢
  • 冠動脈疾患市場企業プロファイル
    • Pfizer Inc.
    • Merck &Co. Inc.
    • AbbVie Inc.
    • Bayer AG
    • Novartis AG

第31章 その他の大手および革新的な企業

  • Sanofi SA
  • Bristol-Myers Squibb Company
  • AstraZeneca plc
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • Gilead Sciences Inc.
  • Amgen Inc.
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Aurobindo Pharma Ltd.
  • Hikma Pharmaceuticals plc
  • Amneal Pharmaceuticals Inc.
  • Chiesi Farmaceutici SpA
  • Lupin Pharmaceuticals Inc.
  • Wockhardt Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13610

Coronary artery disease (CAD) is a medical condition affecting the coronary arteries, responsible for supplying oxygen-rich blood to the heart muscle. The disease occurs when these arteries become narrowed or obstructed due to the accumulation of plaque-a buildup of cholesterol, fat, calcium, and other substances.

Primary treatments for coronary artery disease encompass various approaches such as medication, surgical interventions, additional therapies, and other related strategies. Medications include pharmaceutical substances such as clopidogrel, atorvastatin, metoprolol, lisinopril, losartan, amlodipine, nitroglycerin, among others. Diagnosis involves medical procedures such as electrocardiogram (ECG), echocardiogram, stress tests, cardiac catheterization, heart CT scans, and other diagnostic methods. These medications and diagnostic procedures are made available through diverse distribution channels such as hospital pharmacies, retail pharmacies, online pharmacy platforms, and others. The utilization of these treatments and diagnostic measures extends to hospitals, specialty clinics, and other healthcare facilities.

The coronary artery disease market research report is one of a series of new reports from The Business Research Company that provides coronary artery disease market statistics, including coronary artery disease industry global market size, regional shares, competitors with a coronary artery disease market share, detailed coronary artery disease market segments, market trends and opportunities, and any further data you may need to thrive in the coronary artery disease industry. This coronary artery disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary artery disease market size has grown rapidly in recent years. It will grow from $26.3 billion in 2023 to $28.97 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The observed growth in the historic period can be attributed to several factors. These include the widespread prevalence of coronary artery disease, advancements in minimally invasive surgical techniques contributing to improved treatment options, the rise in sedentary lifestyles impacting cardiovascular health, an aging population leading to increased cases of coronary artery disease, and the evolution and advancement of pharmacological treatments providing better management and care for individuals affected by this condition.

The coronary artery disease market size is expected to see rapid growth in the next few years. It will grow to $42.65 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing impact of lifestyle-related factors on heart health, a heightened focus on telemedicine and remote monitoring for managing coronary artery disease, the expansion of interventional cardiology procedures for improved treatment outcomes, a shift towards value-based healthcare models emphasizing patient outcomes, and the ongoing development of innovative drug therapies for more effective management of the condition. Major trends expected in this forecast period encompass the development of gene therapies targeting heart-related conditions, the integration of artificial intelligence in diagnosing and managing coronary artery disease, a heightened focus on mental health aspects within coronary artery disease care, a rise in home-based healthcare services catering to cardiac patients, and the adoption of remote cardiac rehabilitation programs for enhanced patient recovery and management.

The growth of the coronary artery disease market is anticipated to be fueled by the increasing prevalence of coronary artery disease (CAD). This medical condition is characterized by the narrowing or blockage of coronary arteries, responsible for supplying blood to the heart muscle. Factors contributing to the rise in CAD cases include dietary changes, stress, sedentary lifestyle, obesity, and aging. Treatment modalities for coronary artery disease involve drug interventions such as clopidogrel, ticagrelor, warfarin, and heparin, along with procedural approaches such as coronary artery bypass grafting, angioplasty, and stenting. As per the Centers for Disease Control and Prevention's May 2023 report, coronary heart disease, the most common form of heart disease, claimed 375,476 lives in 2021, affecting approximately 5% of adults aged 20 and above. This prevalence is expected to drive the coronary artery disease market during the forecast period.

The growth trajectory of the coronary artery disease market is further propelled by the rising aging population. An aging population signifies a demographic shift characterized by an increasing proportion of elderly individuals within a society. The demographic trend contributes significantly to the expansion of the coronary artery disease market, given the higher susceptibility of older individuals to this condition. According to the World Health Organization's October 2022 projection, by 2030, one in six individuals globally will be 60 years old or older. During this period, the population aged 60 and over is expected to increase from 1 billion in 2020 to 1.4 billion. Looking ahead to 2050, the global population of individuals aged 60 and older is forecasted to double, reaching 2.1 billion. This demographic shift underlines the role of the rising aging population in propelling the coronary artery disease market.

Prominent companies within the coronary artery disease market are directing their efforts toward developing cutting-edge technologies, including AI-based blood tests. These tests leverage artificial intelligence (AI) algorithms for the analysis and interpretation of blood-related data. For instance, in February 2023, Cardio Diagnostics Holdings, a US-based company specializing in AI-based integrated genetic-epigenetic engines, introduced PrecisionCHD. This innovative blood test combines genetic and epigenetic analyses to enable early identification of coronary heart disease. With a sensitivity of over 75% for both men and women, PrecisionCHD employs a machine-learning model derived from the analysis of billions of genomic and epigenomic data points, incorporating epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers.

Major players in the coronary artery disease market are concentrating on the development of groundbreaking products such as drug-coated balloon catheters. These medical devices are utilized in interventional cardiology procedures to address narrowed or blocked blood vessels, particularly in cases of coronary artery disease or peripheral artery disease. An example is Medtronic PLC, an Ireland-based medical device company, which launched Prevail DCB, the latest-generation drug-coated balloon catheter, in July 2021. Prevail DCB is employed in percutaneous coronary intervention (PCI) procedures to address the narrowing or obstruction of coronary arteries in individuals diagnosed with coronary artery disease (CAD). This emphasis on innovation underscores the commitment of major industry players to advancing technologies for enhanced coronary artery disease management.

In April 2023, Abbott Laboratories, a prominent US-based medical devices and healthcare company, completed the acquisition of Cardiovascular Systems Inc. for a total consideration of $890 million. This strategic acquisition is designed to enhance Abbott's capabilities in addressing vascular disease by integrating the innovative solutions developed and commercialized by Cardiovascular Systems Inc. The latter, based in the United States, is a medical device company with a focus on creating and bringing to market advanced treatments for peripheral and coronary artery disease. This move is indicative of Abbott's commitment to expanding its portfolio and strengthening its position in the medical devices sector, particularly in the field of cardiovascular health.

Major companies operating in the coronary artery disease market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum fur Herz- Kreislauf-Forschung (DZHK) e.V.

North America was the largest region in the coronary artery disease market in 2023. The regions covered in the coronary artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary artery disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coronary artery disease market includes revenues earned by entities by providing coronary angioplasty, coronary artery bypass and heart transplant services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Artery Disease Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coronary artery disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coronary artery disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coronary artery disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Treatment: Medication; Surgery; Additional Therapy; Other Treatments
  • 2) By Diagnosis: Electrocardiogram; Echocardiogram; Stress Test; Cardiac Catheterization; Heart CT Scan; Other Diagnosis
  • 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Channels
  • 4) By End-User: Hospitals; Specialty Clinics; Other End-Users
  • Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Coronary Artery Disease Market Characteristics

3. Coronary Artery Disease Market Trends And Strategies

4. Coronary Artery Disease Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Coronary Artery Disease Market Size and Growth

  • 5.1. Global Coronary Artery Disease Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Coronary Artery Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Coronary Artery Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Coronary Artery Disease Market Segmentation

  • 6.1. Global Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medication
  • Surgery
  • Additional Therapy
  • Other Treatments
  • 6.2. Global Coronary Artery Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Electrocardiogram
  • Echocardiogram
  • Stress Test
  • Cardiac Catheterization
  • Heart CT Scan
  • Other Diagnosis
  • 6.3. Global Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Other Channels
  • 6.4. Global Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End-Users

7. Coronary Artery Disease Market Regional And Country Analysis

  • 7.1. Global Coronary Artery Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Coronary Artery Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Coronary Artery Disease Market

  • 8.1. Asia-Pacific Coronary Artery Disease Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Coronary Artery Disease Market

  • 9.1. China Coronary Artery Disease Market Overview
  • 9.2. China Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Coronary Artery Disease Market

  • 10.1. India Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Coronary Artery Disease Market

  • 11.1. Japan Coronary Artery Disease Market Overview
  • 11.2. Japan Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Coronary Artery Disease Market

  • 12.1. Australia Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Coronary Artery Disease Market

  • 13.1. Indonesia Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Coronary Artery Disease Market

  • 14.1. South Korea Coronary Artery Disease Market Overview
  • 14.2. South Korea Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Coronary Artery Disease Market

  • 15.1. Western Europe Coronary Artery Disease Market Overview
  • 15.2. Western Europe Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Coronary Artery Disease Market

  • 16.1. UK Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Coronary Artery Disease Market

  • 17.1. Germany Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Coronary Artery Disease Market

  • 18.1. France Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Coronary Artery Disease Market

  • 19.1. Italy Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Coronary Artery Disease Market

  • 20.1. Spain Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Coronary Artery Disease Market

  • 21.1. Eastern Europe Coronary Artery Disease Market Overview
  • 21.2. Eastern Europe Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Coronary Artery Disease Market

  • 22.1. Russia Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Coronary Artery Disease Market

  • 23.1. North America Coronary Artery Disease Market Overview
  • 23.2. North America Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Coronary Artery Disease Market

  • 24.1. USA Coronary Artery Disease Market Overview
  • 24.2. USA Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Coronary Artery Disease Market

  • 25.1. Canada Coronary Artery Disease Market Overview
  • 25.2. Canada Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Coronary Artery Disease Market

  • 26.1. South America Coronary Artery Disease Market Overview
  • 26.2. South America Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Coronary Artery Disease Market

  • 27.1. Brazil Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Coronary Artery Disease Market

  • 28.1. Middle East Coronary Artery Disease Market Overview
  • 28.2. Middle East Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Coronary Artery Disease Market

  • 29.1. Africa Coronary Artery Disease Market Overview
  • 29.2. Africa Coronary Artery Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Coronary Artery Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Coronary Artery Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Coronary Artery Disease Market Competitive Landscape And Company Profiles

  • 30.1. Coronary Artery Disease Market Competitive Landscape
  • 30.2. Coronary Artery Disease Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AbbVie Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Coronary Artery Disease Market Other Major And Innovative Companies

  • 31.1. Sanofi S.A.
  • 31.2. Bristol-Myers Squibb Company
  • 31.3. AstraZeneca plc
  • 31.4. Abbott Laboratories
  • 31.5. GlaxoSmithKline plc
  • 31.6. Gilead Sciences Inc.
  • 31.7. Amgen Inc.
  • 31.8. Viatris Inc.
  • 31.9. Teva Pharmaceutical Industries Ltd.
  • 31.10. Aurobindo Pharma Ltd.
  • 31.11. Hikma Pharmaceuticals plc
  • 31.12. Amneal Pharmaceuticals Inc.
  • 31.13. Chiesi Farmaceutici S.p.A.
  • 31.14. Lupin Pharmaceuticals Inc.
  • 31.15. Wockhardt Ltd.

32. Global Coronary Artery Disease Market Competitive Benchmarking

33. Global Coronary Artery Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Coronary Artery Disease Market

35. Coronary Artery Disease Market Future Outlook and Potential Analysis

  • 35.1 Coronary Artery Disease Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Coronary Artery Disease Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Coronary Artery Disease Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer